| pubmed-article:9164228 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0042963 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0209210 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:9164228 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:9164228 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9164228 | pubmed:dateCreated | 1997-6-16 | lld:pubmed |
| pubmed-article:9164228 | pubmed:abstractText | Dolasetron is a 5-HT3 antagonist antiemetic with active oral and intravenous formulations. The effects of this class are enhanced when combined with dexamethasone. This study tested the ability of the combination of oral dolasetron 200 mg and oral dexamethasone 20 mg to prevent acute emesis in cancer patients receiving initial cisplatin at doses > or = 70 mg/m2. Additionally, patients were randomly assigned to receive a second dosage of the regimen 16 hours later to improve control of acute symptoms. | lld:pubmed |
| pubmed-article:9164228 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9164228 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9164228 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9164228 | pubmed:month | May | lld:pubmed |
| pubmed-article:9164228 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:NavariR MRM | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:NelsonA MAM | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:ThomasVV | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:FergusonB BBB | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:ChernoffS BSB | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:KrisM GMG | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:PendergrassK... | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:GroteT HTH | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:BakerT WTW | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:AllmanD SDS | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:PizzoB ABA | lld:pubmed |
| pubmed-article:9164228 | pubmed:author | pubmed-author:FernandoI JIJ | lld:pubmed |
| pubmed-article:9164228 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9164228 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:9164228 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9164228 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9164228 | pubmed:pagination | 2135-8 | lld:pubmed |
| pubmed-article:9164228 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:meshHeading | pubmed-meshheading:9164228-... | lld:pubmed |
| pubmed-article:9164228 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9164228 | pubmed:articleTitle | Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone. | lld:pubmed |
| pubmed-article:9164228 | pubmed:affiliation | Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. krism@mskcc.org | lld:pubmed |
| pubmed-article:9164228 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9164228 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9164228 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9164228 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9164228 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
